| Literature DB >> 29862120 |
Sabriye Yusan1,2, Mokhlesur M Rahman3, Nasir Mohamad3, Tengku M Arrif3, Ahmad Zubaidi A Latif4, Mohd Aznan M A5, Wan Sani B Wan Nik6.
Abstract
A new bioenzymatic glucose biosensor for selective and sensitive detection of glucose was developed by the immobilization of glucose oxidase (GOD) onto selenium nanoparticle-mesoporous silica composite (MCM-41) matrix and then prepared as a carbon paste electrode (CPE). Cyclic voltammetry was employed to probe the catalytic behavior of the biosensor. A linear calibration plot is obtained over a wide concentration range of glucose from 1 × 10-5 to 2 × 10-3 M. Under optimal conditions, the biosensor exhibits high sensitivity (0.34 µA·mM-1), low detection limit (1 × 10-4 M), high affinity to glucose (Km = 0.02 mM), and also good reproducibility (R.S.D. 2.8%, n=10) and a stability of about ten days when stored dry at +4°C. Besides, the effects of pH value, scan rate, mediator effects on the glucose current, and electroactive interference of the biosensor were also discussed. As a result, the biosensor exhibited an excellent electrocatalytic response to glucose as well as unique stability and reproducibility.Entities:
Year: 2018 PMID: 29862120 PMCID: PMC5971259 DOI: 10.1155/2018/2687341
Source DB: PubMed Journal: J Anal Methods Chem ISSN: 2090-8873 Impact factor: 2.193
Comparison between current market CGMS/sensor results devices [26–28].
| Brand | Guardian Real-Time | MiniMed 530G with Enlite | Dexcon G4 Platinum | FreeStyle |
|---|---|---|---|---|
| Company | Medtronic | Medtronic | Dexcom | Abbott |
| FDA approved date | 2006 | 2007 | 2007 | 2008 |
| Sensor life (d) | 3 | 6 | 7 | 5 |
| Sensor style | Insertion under skin | Insertion under skin | Insertion under skin | Insertion under skin |
| Startup initialization time (h) | 2 | 2 | 2 | 10 |
| Calibration (Y/N) with finger-stick test | Y, 2 h after insertion, the first 6 h, and then every 12 h | Y, 2 h after insertion, the first 6 h, and then every 12 h | Y, every 12 h | Y, approximately 1, 2, 10, 24, and 72 h after insertion |
CGMS = continuous glucose monitor system; FDA = Food and Drug Administration.
Figure 1Cyclic voltammogram of (I) Se-MCM-41 and (II) immobilized GOD to the Se-MCM-41 in 0.05 M phosphate buffer (pH 7) at a scan rate of 20 mV·s−1.
Figure 2Cyclic voltammograms of Se-MCM-41/GOD/CPE in pH 7.0 PBS at 20, 40, 60, 80, and 100 mV·s−1 scan rates (from inner to outer). Inset: peak currents of plots versus v1/2.
Figure 3Effect of pH on the response of the biosensor (Se-MCM-41/GOD/CPE) in the presence of 2 mM glucose.
Figure 4Correlation between the maximum current and the concentration of glucose.
Figure 5Cyclic voltammograms of Se-MCM-41/GOD/CPE in 0.05 M PBS (pH 7.0) containing 0.2 mM ferrocene in the absence (a) and presence (b) of 2.0 mM glucose.